174 related articles for article (PubMed ID: 29030979)
1. Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.
Tsubaki M; Takeda T; Tomonari Y; Kawashima K; Itoh T; Imano M; Satou T; Nishida S
J Cell Physiol; 2018 Apr; 233(4):3638-3647. PubMed ID: 29030979
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of peroxisome proliferator-activated receptor γ agonist through activation of Akt and signal transducers and activators of transcription 3 in transient forebrain ischemia.
Sui X; Yoshioka H; Wakai T; Fukumoto Y; Kinouchi H
Neuroreport; 2020 Apr; 31(6):484-489. PubMed ID: 32243355
[TBL] [Abstract][Full Text] [Related]
3. The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
Plissonnier ML; Fauconnet S; Bittard H; Lascombe I
PLoS One; 2011; 6(12):e28354. PubMed ID: 22174792
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.
Al-Taie OH; Graf T; Illert B; Katzenberger T; Mörk H; Kraus MR; Barthelmes HU; Scheurlen M; Seufert J
J Gastroenterol; 2009; 44(9):919-29. PubMed ID: 19506796
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway.
Jiao XX; Lin SY; Lian SX; Qiu YR; Li ZH; Chen ZH; Lu WQ; Zhang Y; Deng L; Jiang Y; Hu GH
Neoplasma; 2020 Jul; 67(4):834-842. PubMed ID: 32386478
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
11. Activation of β2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARγ.
Zhou J; Liu Z; Zhang L; Hu X; Wang Z; Ni H; Wang Y; Qin J
Cancer Res Treat; 2020 Jul; 52(3):830-847. PubMed ID: 32138468
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells.
Lee CJ; Han JS; Seo CY; Park TH; Kwon HC; Jeong JS; Kim IH; Yun J; Bae YS; Kwak JY; Park JI
Apoptosis; 2006 Mar; 11(3):401-11. PubMed ID: 16520894
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1.
Göke R; Göke A; Göke B; El-Deiry WS; Chen Y
Digestion; 2001; 64(2):75-80. PubMed ID: 11684819
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARγ.
Ji HG; Piao JY; Kim SJ; Kim DH; Lee HN; Na HK; Surh YJ
Mol Nutr Food Res; 2016 Jun; 60(6):1448-57. PubMed ID: 27079734
[TBL] [Abstract][Full Text] [Related]
16. [Activation of PPARγ pathway enhances cellular anti-oxidant capacity to protect long-term cultured primary rat neural cells from apoptosis].
Wang H; Fan J; Chen W; Gao Z; Zhang G; Wu H; Yu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):23-29. PubMed ID: 30692062
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone, a PPARgamma ligand, suppresses NFkappaB activation through inhibition of IkappaB kinase activation in cerulein-treated AR42J cells.
Wan H; Yuan Y; Qian A; Sun Y; Qiao M
Biomed Pharmacother; 2008 Sep; 62(7):466-72. PubMed ID: 18490130
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.
Wang D; Ning W; Xie D; Guo L; DuBois RN
Oncogene; 2012 Feb; 31(8):1013-23. PubMed ID: 21765467
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
